News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,056 Results
Type
Article (40030)
Company Profile (249)
Press Release (659777)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (204431)
Career Advice (2009)
Deals (35458)
Drug Delivery (95)
Drug Development (81269)
Employer Resources (172)
FDA (16203)
Job Trends (14873)
News (345713)
Policy (32599)
Tag
Academia (2564)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49526)
ALS (89)
Alzheimer's disease (1381)
Antibody-drug conjugate (ADC) (126)
Approvals (16204)
Artificial intelligence (254)
Autoimmune disease (21)
Automation (16)
Bankruptcy (361)
Best Places to Work (11645)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (176)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (279)
Cancer (2269)
Cardiovascular disease (178)
Career advice (1678)
Career pathing (30)
CAR-T (152)
Cell therapy (426)
Cervical cancer (19)
Clinical research (66155)
Collaboration (838)
Company closure (1)
Compensation (547)
Complete response letters (19)
COVID-19 (2593)
CRISPR (42)
C-suite (241)
Cystic fibrosis (100)
Data (2211)
Decentralized trials (2)
Denatured (18)
Depression (44)
Diabetes (271)
Diagnostics (6378)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86687)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112562)
Executive appointments (723)
FDA (17468)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (749)
Gene editing (108)
Generative AI (19)
Gene therapy (304)
GLP-1 (713)
Government (4423)
Grass and pollen (4)
Guidances (68)
Healthcare (18836)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (118)
Indications (29)
Infectious disease (2735)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (96)
Interviews (311)
IPO (16514)
IRA (40)
Job creations (3638)
Job search strategy (1424)
Kidney cancer (10)
Labor market (38)
Layoffs (470)
Leadership (17)
Legal (7921)
Liver cancer (75)
Lung cancer (320)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (305)
MASH (68)
Medical device (13393)
Medtech (13398)
Mergers & acquisitions (19487)
Metabolic disorders (687)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (28)
Neuroscience (1921)
NextGen: Class of 2025 (6547)
Non-profit (4482)
Now hiring (39)
Obesity (364)
Opinion (206)
Ovarian cancer (76)
Pain (88)
Pancreatic cancer (84)
Parkinson's disease (149)
Partnered (21)
Patents (233)
Patient recruitment (112)
Peanut (46)
People (57361)
Pharmaceutical (64)
Pharmacy benefit managers (18)
Phase I (20623)
Phase II (29142)
Phase III (21691)
Pipeline (1214)
Policy (140)
Postmarket research (2569)
Preclinical (8768)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (251)
Rare diseases (384)
Real estate (5919)
Recruiting (65)
Regulatory (22333)
Reports (46)
Research institute (2329)
Resumes & cover letters (349)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (130)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3591)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (30)
Vaccines (693)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Today (37)
Last 7 days (852)
Last 30 days (2504)
Last 365 days (32698)
2025 (10797)
2024 (35273)
2023 (40136)
2022 (51255)
2021 (55759)
2020 (54126)
2019 (46609)
2018 (35073)
2017 (32183)
2016 (31549)
2015 (37598)
2014 (31369)
2013 (26407)
2012 (28622)
2011 (29300)
2010 (27372)
Location
Africa (719)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (37984)
Australia (6224)
California (6147)
Canada (2020)
China (525)
Colorado (266)
Connecticut (274)
Delaware (148)
Europe (81516)
Florida (912)
Georgia (206)
Idaho (57)
Illinois (536)
India (25)
Indiana (309)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4582)
Michigan (220)
Minnesota (392)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1728)
New Mexico (28)
New York (1751)
North Carolina (968)
North Dakota (8)
Northern California (2689)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1380)
Puerto Rico (12)
Rhode Island (33)
South America (1099)
South Carolina (23)
South Dakota (1)
Southern California (2311)
Tennessee (101)
Texas (909)
United States (23172)
Utah (182)
Virginia (146)
Washington D.C. (62)
Washington State (554)
West Virginia (3)
Wisconsin (54)
700,056 Results for "alpha genesis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alpha Genesis Proposes Innovative Management Model to Transform National Primate Research Centers
March 6, 2025
·
2 min read
Press Releases
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q4 2024
April 1, 2025
·
1 min read
Press Releases
Next Generation Targeted Alpha Therapy Clinical Trials Development Insight
“Currently More Than 20 Targeted Alpha Therapies Are In Clinical Trials”
January 29, 2025
·
1 min read
Press Releases
Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (ACOG)
January 30, 2025
·
1 min read
Press Releases
Alpha Cognition to Report First Quarter 2025 Financial Results and Operating Overview
May 1, 2025
·
4 min read
Press Releases
Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration
February 20, 2025
·
4 min read
Press Releases
ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225
April 24, 2025
·
4 min read
Press Releases
FDA Approves AChEI ALPHA-1062 for Alzheimer’s Disease Treatment
On July 29, 2024, the U.S. FDA approved Alpha Cognition Inc.'s ALPHA-1062 (Zunveyl®), an Acetylcholinesterase (AChE) inhibitor, for treating mild-to-moderate Alzheimer’s disease.
August 2, 2024
·
2 min read
Press Releases
Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Clinical Data at 2025 Alzheimer’s Association International Conference
April 28, 2025
·
6 min read
Press Releases
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
April 29, 2025
·
6 min read
1 of 70,006
Next
